BAC Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
BAC General Information
Description
Provider of affinity purification products and services for the biopharmaceutical market. The company develops affinity ligands and affinity purification products for the biopharmaceutical research and production market. The company also offers affinity separation products for the discovery, preclinical and clinical manufacturing of therapeutic proteins, antibodies and antibody fragments, vaccines and viruses.
Contact Information
Corporate Office
- Huizerstraatweg 28
- 1411 GP Naarden
- Netherlands
Corporate Office
- Huizerstraatweg 28
- 1411 GP Naarden
- Netherlands
BAC Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BAC Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BAC FAQs
-
When was BAC founded?
BAC was founded in 1995.
-
Where is BAC headquartered?
BAC is headquartered in Naarden, Netherlands.
-
What industry is BAC in?
BAC’s primary industry is Biotechnology.
-
Is BAC a private or public company?
BAC is a Private company.
-
What is BAC’s current revenue?
The current revenue for BAC is .
-
How much funding has BAC raised over time?
BAC has raised $6.77M.
-
Who are BAC’s investors?
Fleming Family & Partners, Unilever, and Unilever Ventures have invested in BAC.
-
When was BAC acquired?
BAC was acquired on 22-Jan-2013.
-
Who acquired BAC?
BAC was acquired by Invitrogen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
